Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Understand how tax efficiency varies among total market funds, and what factors influence after-tax returns for retirement investing.
28,571 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As markets shift in 2026, retirees are seeking reliable income with inflation protection. This article breaks down fo...
Cloudflare shares climbed about 8% on the day as investors bet NVIDIA’s AI acceleration will push more traffic throug...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...
Aveanna's Q1 2026 results shed light on how the company is navigating labor costs, payer mix, and geographic expansio...
Arm stock skyrocketed this week as AI enthusiasm and licensing momentum collided with bullish analyst coverage. This ...
A global memory crunch has propelled Micron to the forefront of AI-era investing. This article breaks down the why, w...
A single conference-call moment changed the mood around Eli Lilly. By unpacking eight key themes from the CEO, invest...
Mid-June market data show the Russell 2000 leading the pack, up around 18% year-to-date as small caps take the spotli...
Bitcoin tumbled in a rapid flash dump as tariff headlines roiled markets, sparking risk-off selling and erasing sever...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...